Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2016 Mar 8;11(3):e0150647. doi: 10.1371/journal.pone.0150647

Simultaneous Qualitative Assessment and Quantitative Analysis of Metabolites (Phenolics, Nucleosides and Amino Acids) from the Roots of Fresh Gastrodia elata Using UPLC-ESI-Triple Quadrupole Ion MS and ESI- Linear Ion Trap High-Resolution MS

Sha Chen 1, Jun Qiu Liu 1, Hui Xiao 1, Jun Zhang 1, An Liu 1,*
Editor: Hua Zhou2
PMCID: PMC4783114  PMID: 26954012

Abstract

A sensitive, effective and optimized method, based on ultra performance liquid chromatography (UPLC) coupled with ESI-triple quadrupole ion MS and ESI-linear ion trap high-resolution MS, has been developed for the simultaneous quantitative and qualitative determination of phenolics, nucleosides and amino acids in the roots of fresh Gastrodia elata. Optimization of the analytical method provided higher separation efficiency and better peak resolution for the targeted compounds. The simultaneous separation protocols were also optimized by routinely using accurate mass measurements, within 5 ppm error, for each molecular ion and the subsequent fragment ions. In total, 31 compounds, including 23 phenolics, two nucleosides, four amino acids, one gastrodin and one other compound were identified or tentatively characterized. Mono-substituted parishin glucoside (9), methoxy mono-substituted parishin (13), methyl parishin (26), p-hydroxybenzyl di-substituted parishin (29), and p-hydroxybenzyl parishin (31) were tentatively identified as new compounds. Principal metabolite content analysis and the composition of eight representative G. elata cultivars of various species indicated that geographic insulation was the main contributor to clustering.

Introduction

Gastrodia elata (G. elata) is frequently used in traditional Chinese medicine (TCMs). TCMs made from root extractsare mainly used to treat vertigo, blackouts, headaches, dizziness, rheumatism, hemiplegia, and epileptic convulsions [13]. Many bioactive compounds have been isolated from G. elata, which include phenolics (4-hydroxybenzaldehyde, 4-hydroxybenzyl alcohol, gastrodin, and parishin), citric acid, and amino acids [4,5]. In recent years, the use of G. elata has increased rapidly as commercial preparations have become more readily available [6]. The compounds found in G. elata have been reported to possess anti-epileptic [7], anti-obesity [8], anti-convulsive [9], anti-oxidative [10] and memory enhancing properties [11].

The pharmacological properties of G. elata extracts are largely attributable to the presence of accumulated secondary metabolites. Although metabolite studies have, so far, focused mainly on the medicinal properties of G. elata products and extracts, a metabolite survey could also provide information about the genetic and biochemical control of the metabolism during the plant’s development. Additionally, G. elata may provide an interesting model for studying other biological processes and metabolic regulation [1214].

The most abundant compound in G. elata, and also the main active ingredient, is parishin, an ester formed by the condensation of three gastrodin subunits. However, the Chinese Pharmacopoeia [15] designates parishin as the only characteristic ingredient of G. elata. Recently, though, many more compounds have been identified in G. elata by using mass spectrometry (MS). In one study [16], some parishin compounds that would be expected to occur in G. elata were not identified, and only m/z values of those identified in MS process were presented. It was challenging to make progress in the analysis of G. elata compounds. Furthermore, little information is available about the composition and content of metabolites in different cultivars of G. elata, as well as the relationship between the G. elata cultivars and their area of origin. A survey of these cultivars and their areas of orgin would therefore be valuable.

In addition to the above issues, separation efficiency and resolution of target peaks of compounds extracted from plant are common bottlenecks in the qualitative and quantitative analysis of metabolism [17]. If suitable separation protocols can't be established, the use of inappropriate protocols may influence the results of an analysis. The purpose of the present study was to develop a complete systematic method for the qualitative and quantitative analysis of the major bioactive compounds extracted from roots of G. elata by using ultra performance liquid chromatography (UPLC) coupled with ESI-triple quadrupole ion MS and ESI-linear ion trap high-resolution MS. To the best of our knowledge, this is a report describing a simple and time-saving analytical method for the simultaneous determination of multiple metabolites in fresh root samples from G. elata.

Experimental

The study was carried out on private land and we confirmed that the owner of the land gave us the permission to conduct the study on this site.

Chemicals and standards

HPLC grade acetonitrile used for HPLC-MS analysis, including acetonitrile and formic acid, were of HPLC grade (CNW, Dusseldorf, Germany). Formic acid was HPLC-grade obtained from Sigma-Aldrich (St. Louis, MO, USA). Waters used in the experiment was de-ionized and further purified by a Milli-Q Plus water purification system (Millipore Ltd.). Other reagents and chemicals were of analytical grade purchased from Beijing Chemistry factory Corporation. Gastrodin, parishin E, parishin B, and parishin were purchased from the National Institute for the control of Biological and Pharmaceutical Drugs (Beijing, China).

Plant materials

Rhizomes from eight G. elata cultivars were collected from three independent populations; each population contained 60 individual plants. The eight cultivars were of four species (green, red, black, and hybrid) obtained from four representative provinces (Table 1). Three replicates of eight cultivars were manually collected in late December (12/24, 2013) from three individual plants of each cultivars. The collected rhizomes specimens were identified as Gastrodia elata Bl by a taxonomist (Professor Ming Cheng) at Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.

Table 1. G. elata cultivars used in this study.

Cultivars Genotype groups Place of collection (City-Province) Coordinates (Latitude-Longitude) Time of collection
1 Red# Bijie-Guizhou 27°18'-105°18' December 21, 2013
2 Green# Bijie-Guizhou 27°18'-105°18' December 21, 2013
3 Black# Bijie-Guizhou 27°18'-105°18' December 21, 2013
4 Red# Yaan-Sichuan 29°59'-103°01' December 22, 2013
5 Green# Yaan-Sichuan 29°59'-103°01' December 22, 2013
6 Hybrid# Yaan-Sichuan 29°59'-103°01' December 22, 2013
7 Red# Hanzhong-Shanxi 33°04'-107°01' December 24, 2013
8 Hybrid# Zhaotong-Yunnan 27°20'-103°43' December 25, 2013

Sample preparation

For each freeze-dried sample of G. elata root, a portion (0.5 g, 100 mesh) was accurately weighed into a 50 mL flask and extracted with 20 mL 50% aqueous methanol (methanol: water 50:50, v/v) in an ultrasonic bath for 30 min at room temperature. Each extract combination was performed in triplicate. The extract was centrifuged for 5 min at 15, 000 g, the supernatant was collected and all the samples were re-extracted as above twice more. The combined supernatant was then filtered through a 0.22-μm Millipore filter (Alltech Scientific Corporation, Beijing, China) before injection for LC/MS analysis.

UPLC method

Chromatographic separation was performed using a UPLC system (DaianU3000, Dionex Corparation, CA, USA). The equipment comprised an UPLC pump, a photodiode array (PDA) detector, and an auto-sampler set at 30°C. Phenolic detection in diode array detector was carried out at 270 nm, and spectrum scans were made from 200 to 400 nm. Separations were carried out using an Accucore C18 column (2.1 mm × 100 mm, 2.6 μm particle size, Thermo Fisher Scientific, Bellefonte, PA, USA). The mobile phase consisted of water containing 0.1% formic acid (A) and acetonitrile (B). Linear gradient elution was performed at a flow rate of 0.2 mL/min. The solvent gradient was changed according to the following program: 0–8 min, 2% B; 8–12 min, 2–8% B; 12–25 min, 8–12% B; and 25–47 min, 12–25% B. The injection volume was 1 μL and chromatograms were acquired at 270 nm.

Q-Trap MS

MS analysis was performed using an LTQ Orbitrap mass spectrometer (Thermo Fisher Scientific, San Jose, CA, USA), fitted with an electrospray ionization (ESI) source operated in both negative and positive modes. The m/z range was 100–1200, with resolution set at 30000 using the normal scan rate. Data-dependent MS/MS events were always performed on the most intense ions detected in the full scan MS. The normalized collision energy was 30% for all compounds. Nitrogen was used as the sheath gas and helium as the collision gas. The key optimized ESI parameters were as follows: source voltage, 3.0 kV; sheath gas (nitrogen), 50 L/min; auxiliary gas flow, 10 L/min; capillary voltage, -35.0 V; capillary temperature, 350°C, and tube lens, -110.0 V. The ion injection time used was 50.0 ms. MS scan functions and UPLC solvent gradients were controlled by an X-calibur data system (Thermo Fisher, Scan Jose, CA, USA).

ESI-QQQ-MS

Triple quadrupole (QQQ) scans were acquired using an Agilent 1290 UPLC-photodiode array 6460 triple quadrupole mass spectrometry system (Agilent Technologies, Palo Alto, CA, USA). The ESI source operation parameters were as follows: HV voltage, 3.5 kV; capillary, 7 μA; nozzle voltage, 500 V; delta emv, 300 V; gas flow, 5 L/min; gas temp, 350°C; nebulizer, 45 psi; sheath gas temp, 350°C; and sheath gas flow, 11 L/min.

Method validation

The method was validated by characteristic indexes including linearity, the limit of detection (LOD), the limit of quantification (LOQ) and precision (inter-day. intra-day precision).

Statistical analysis

Quantitative data were analyzed with SPSS 16.0 for window. Principal component analyses (PCA) for identifying homogeneous groups of individual tissues based on measured phenolics, nucleosides and amino acids concentrations were performed in SPSS 16.0. Factors were identified using varimax rotation and the two most significant factors were extracted using the Kaiser-Meyer-Olkin criterio (KMO).

Results and Discussion

Optimization of HPLC and MS conditions

In preliminary tests, three columns were evaluated for the separation of target compounds from the roots of G. elata. These were a SunFire C18 column (2.1 mm × 100 mm, 1.9 μm particle size, Waters Corporation, Milford, USA) (Fig 1A-I), an Acquity BEH C18 column (2.1 mm × 100 mm, 1.7 μm particle size, Waters Corporation, Milford, USA) (Fig 1A-II), and an Accucore C18 column (2.1 mm × 100 mm, 2.6 μm particle size, Thermo Scientific, USA) (Fig 1A-III). Using the same elution protocol, the Accucore C18 column (Fig 1A-III) gave slightly better resolution than the other two columns. Thus, it indicated that particle size may be an important factor affecting the resolution of compounds in G. elata. Based on earlier reports, two elution systems (Fig 1B-I and 1B-II) were then evaluated to optimize the peak shapes of metabolites separated from G. elata. Elution system B-I, in which acetic acid was added to the eluent, was based on research carried out by Wang [18], and allowed identification of 15 phenolics and 6 nucleoside derivatives in the roots of G. elata. Elution system B-II, in which 0.1% formic acid was added to the mobile phase, was based on research carried out by Ong et al. [19] and has been widely used to separate phenolics from the roots of G. elata. In the present study, we found that a higher concentration of formic acid (0.5%, v:v, B-III) improved peak separation efficiency (Fig 1B-III). Our research suggests that an Accucore C18 column and a mobile phase containing formic acid (0.5%) is suitable for the analysis of metabolites in G. elata. The optimized experiment condition was replicated for eight different cultivars analysis.

Fig 1.

Fig 1

Optimized HPLC chromatograms at 220 nm selected from three column system (AI—AIII) and three mobile protocols (BI-BIII). Thirty-one compounds (peaks 1–31) were separated by BIII and identified using UPLC- LTQ Orbitrap mass spectrometry.

Method validation

Calibration curves, limits of detection and quantification

Method validation was carried out using four external standards (gastrodin, parishin E, parishin B, and parishin). The calibration curves showed good linearity for all standards at 350 nm (r2 ≥ 0.9915). The standard solutions were detected by chromatography until the signal-to-noise (S/N) ratios were 3 and 10; the corresponding concentrations at these S/N ratios were defined as the LOD and LOQ, respectively. The lowest and highest LOD and LOQ were obtained for gastrodin (0.024 and 0.081 μg/mL) and parishin (0.359 and 1.196 μg/mL) (Table 2).

Table 2. The regression equation, LOD and LOQ of the four standards using the optimized method for calibration.
Compounds Regression equation r2 Linear range (μg/mL) LOD (μg/mL) LOQ (μg/mL)
Gastrodin y = 79899x - 1108.1 0.9999 8.89–44.48 0.024 0.081
Parishin E y = 19656x - 12538 0.9915 6.08–60.80 0.143 0.475
Parishin B y = 19656x - 12538 0.9981 34.50–138.00 0.104 0.345
Parishin y = 315580x - 7052.4 0.9999 40.66–203.30 0.359 1.196

y, peak area; x, compound concentration (μg/mL); LOD = limit of detection, S/N = 3; LOQ = limit of quantitation, S/N = 10

Precision and accuracy of quantification

The precision of metabolite quantification was studied by examining the repeatability and intermediate precision for all compounds separated from G. elata roots. Six standard samples were evaluated on the same day to determine the intra-day precision. Three samples were also extracted and analyzed on three consecutive days to determine the inter-day precision. Sample solutions were prepared at three concentrations (low, middle, and high), with three replicates of each concentration in order to validate method precision. Relative standard deviations (RSDs) were calculated to assess repeatability and precision. The RSDs of the four compounds were less than 4.05% for inter-day precision at the three concentration and 4.00% for the intra-day precision (Table 3). The low RSD values obtained for the four compounds confirmed the high repeatability and intermediate precision of the method developed here.

Table 3. Intra- and inter-day precision of four standards by HPLC.
Compounds Intra-day(n = 6) Inter-day(n = 3)
Concentration (μg/mL) RSD (%) Concentration (μg/mL) RSD b (%)
Gastrodin 9.48 ± 0.38 a 4.00 9.30 ± 0.23 2.46
15.85 ± 0.59 3.72 15.15 ± 0.30 2.01
27.09 ± 0.34 1.25 27.09 ± 0.45 1.34
Parishin H 6.40 ± 0.21 3.35 6.29 ± 0.15 2.42
8.99 ± 0.23 2.72 8.98 ± 0.15 1.48
20.58 ± 0.66 3.18 20.02 ± 0.81 4.05
Parishin B 35.82 ± 0.59 1.67 35.76 ± 0.67 1.87
57.56 ± 0.74 1.28 59.52 ± 0.78 1.30
118.34 ± 0.60 0.51 118.39 ± 0.66 0.21
Parishin 50.88 ± 0.85 1.66 51.77 ± 0.41 0.80
83.80 ± 0.61 0.72 84.08 ± 0.27 0.32
167.23 ± 0.94 0.56 167.90 ± 0.81 0.48

a Mean concentration ± SD.

b RSD = (SD/mean) × 100

Accuracy and recovery of quantification

The accuracy of the method was investigated by measuring the recovery. This was assessed by adding three concentrations (high, middle and low) of standard solutions to known amounts of sample solution which were then extracted and subjected to quantitative analysis as described above. Each standard was tested at each concentration in triplicate. The equation used to define the percentage recovery was (detected amount—original amount)/spiked amount x 100. Recoveries obtained in this study were in the range 88.02–105.38% (Table 4), demonstrating that the analytical method developed in this study has high accuracy. The low RSDs of all standards (< 1.54%) indicate good reproducibility.

Table 4. Recovery of four standards in the extraction of GE (n = 3).
Compounds Initial amount (mg) Added amount (mg) Total recovered amounta (mg) Recoveryb (%) RSDc (%)
Gastrodin 1.09 0.62 1.62 ± 0.01 88.02 1.26
1.09 2.24 3.35 ± 0.03 100.91 1.54
1.09 3.86 4.93 ± 0.01 99.65 0.30
Parishin E 1.22 0.42 1.62 ± 0.02 94.65 0.57
1.22 2.04 3.33 ± 0.03 105.38 1.46
1.22 4.11 5.01 ± 0.03 92.15 0.70
Parishin B 1.14 0.32 1.43 ± 0.00 89.88 0.52
1.14 1.72 2.88 ± 0.01 101.96 0.58
1.14 3.45 4.35 ± 0.00 92.85 0.13
Parishin 2.55 2.87 5.34 ± 0.01 97.66 0.34
2.55 8.23 10.78 ± 0.02 100.43 0.00
2.55 13.86 16.21 ± 0.01 98.49 0.07

a Total recovered amount = mean content ± SD.

b Recovery (%) = (detected amount—original amount)/spiked amount × 100.

c RSD = (recovery SD/mean) × 100

Analysis of constituents in G. elata

The identification of 31 compounds was performed in both positive and negative modes. Chemical structures, mass spectra (in PI, NI and NI-MS/MS), retention times, UV-Vis spectra, and retention times on the C18 column are listed in Table 5. The identified compounds could be classified into three groups, phenolics, nucleosides and amino acids, based on their chemical structures.

Table 5. Characterization of constituents extracted from gastrodia by ESI- linear ion trap high-resolution MS.

No. Rt (min) NI PI+ λmax (nm) Identification
[M-H], [M+HCOO] Fragment ions [M+H]+, [M+Na]+ Fragment ions ppm
1 2.44 191.0198 111.10[M-H-2H2O-CO2], 173.10[M-H-H2O] 215.0160 197.10[M+Na-H2O]+ 256 Citric Acid
2 3.17 243.0123 267.0196 113.10[M+H-132]+ 262 Uridine
3 3.51 180.1078 182.1056 165.10[M+H-NH3]+, 136.10[M+H-HCOOH]+ 0.987 220 Tyrosine
4 3.74 132.1020 115.10[M+H-NH3]+, 86.10[M+H-HCOOH]+ 0.721 217 Leucine
5 4.82 266.1567 134.12[M-H-132] 268.1031 136.10[M+H-132]+ 1.344 259 Adenosine
6 6.36 331.1044 161.12[Glu-H], 123.12[M-Glu-H] 309.0925 185.10[Glu+Na]+ 0.537 220 Gastrodin
7 8.12 127.1091 108.10[M+H- H2O]−+ 285 5-hydroxymethyl fural
8 11.37 123.1098 105.12[M-H- H2O] 0.503 220 P-hydroxybenzyl alcohol
9 21.83 621.1660 441.10[M-H-162-H2O], 459.10[M-H-162], 397.10[M-H-162-H2O-CO2], 369.10[M-H-162-CO2] 645.1136 539.10[M+Na-106]+, 483.10[M+Na-162]+, 377.10[M+Na-268]+, 215.10[M+Na-268-162]+ 0.411 222 Mono-substituted parishin glucoside
10 23.25 459.1145 173.10[M-H-268-H2O], 129.10[M-H-268-H2O-CO2] 483.1123 377.11[M+Na-106]+, 321.11[M+Na-162]+, 215.11[M+Na -268]+, 185.11[Glu+Na]+ 0.493 221 parishin H
11 25.15 459.1145 173.10[M-H-268-H2O], 129.10[M-H-268-H2O-CO2] 483.1091 377.10[M+Na-2CO2-H2O]+, 321.10[M+Na-162]+, 215.10[M+Na -268]+, 185.10[Glu+Na]+ 0.679 221 parishin E
12 25.72 412.1178 306.10[M-H-106] 414.1331 339.10[M+H-75]+, 308.10[M+H-106]+, 285.12[M+H-147+H2O]+, 179.12[M+H-147+H2O-106]+, 233.12[M+H-106-75]+ 2.094 224 S-(4-hydroxybenzyl) -glutathione
13 27.94 489.1247 427.10[M-H-H2O-CO2], 173.10[M-H-268-H2O-30] 513.1048 377.00[M+Na-2Co2-H2O]+, 215.10[M+Na-268-30]+ 0.436 223 Methoxy mono-substituted parishin
14 30.82 518.1593 412.10[M-H-162-106], 306.10[M-H-162-106-106] 520.3333 377.10[M+Na-2CO2-H2O-30]+, 339.10[M+H-75-106]+, 308.10[M+H-106-106]+, 285.10[M+H-147+H2O-106]+, 233.10[M+H-106-75-106]+, 179.10[M+H-147+H2O-106-106]+ 0.458 224 P-hydroxybenzyl s-(4-hydroxybenzyl) -glutathione
15 32.91 889.2617 621.10[M-H-268], 603.10[M-H-268-H2O], 585.10[M-H-268-2H2O], 559.10[M-H-268-H2O-CO2], 531.10[M-3H-268-2CO2], 423.10[M-H-268-2H2O-162], 397.10[M-H-268-H2O-CO2-162] 913.2527 807.11[M+Na-106]+, 645.11[M+Na-268]+, 483.11[M+Na-268-162]+ 224 Di-substituted parishin glucoside
16 35.50 727.2083 471.10[M-H-268-H2O], 453.10[M-H-268-2H2O], 423.10[M-H-268-2H2O-30], 397.10[M-H-268-H2O-CO2], 369.10[M-3H-268-2CO2-30] 751.2071 645.10[M+Na-106]+, 483.10[M+Na-268]+, 539.10[M+Na-106-106]+, 589.10[M+Na-162]+, 377.10[M+Na-106-268]+, 215.10[M+Na-268-268]+ 0.582 222 Di-substituted parishin
17 36.13 727.2092 459.10[M-H-268], 441.10[M-H-268-H2O], 423.10[M-H-268-2H2O], 397.10[M-H-268-H2O-CO2], 369.10[M-3H-268-2CO2] 751.4514 645.10[M+Na-106]+, 483.10[M+Na-268]+, 539.10[M+Na-106-106]+, 589.10[M+Na-162]+, 377.10[M+Na-106-268]+, 215.10[M+Na-268-268]+ 0.692 222 parishin B
18 36.22 889.2617 621.10[M-H-268], 603.10[M-H-268-H2O], 585.10[M-H-268-2H2O], 559.10[M-H-268-H2O-CO2], 531.10[M-3H-268-2CO2], 423.10[M-H-268-2H2O-162], 397.10[M-H-268-H2O-CO2-162] 913.1057 807.10[M+Na-268+Glc]+, 645.10[M+Na-268]+, 483.10[M+Na-268-162]+ 224 Di-substituted parishin glucoside isomer
19 37.26 757.2189 471.10[M-H-268-H2O], 453.10[M-H-268-2H2O], 423.11[M-H-268-2H2O-30], 397.10[M-H-268-H2O-CO2], 369.10[M-3H-268-2CO2-30] 781.4503 483.10[M+Na-268-162-30]+, 513.10[M+Na-268]+, 675.10[M+Na-268+Glu]+ 5.178 225 Methoxy di-substituted parishin
20 37.98 727PONE-D-15-37678R3.2070 459.10[M-H-268], 441.10[M-H-268-H2O], 423.10[M-H-268-2H2O], 397.10[M-H-268-H2O-CO2], 369.10[M-3H-268-2CO2] 751.2071 645.10[M+Na-106]+, 483.10[M+Na-268]+, 539.10[M+Na-106-106]+, 589.10[M+Na-162]+, 377.10[M+Na-106-268]+, 215.10[M+Na-268-268]+ 3.049 222 parishin C
21 39.11 757.2189 471.10[M-H-268-H2O], 453.10[M-H-268-2H2O], 423.10[M-H-268-2H2O-30], 397.10[M-H-268-H2O-CO2], 369.10[M-3H-268-2CO2-30] 781.4555 483.10[M+Na-268-162-30]+, 513.10[M+Na-268]+, 675.10[M+Na-268+Glu]+ 5.178 225 Methoxy di-substituted parishin isomer
22 39.51 741.2240 741.10[M-H], 473.10[M-H-268], 441.10[M-H-268-H2O-14] 765.2215 659.10[M+Na-106]+, 603.10[M+Na-162]+, 497.10[M+Na-268-14]+, 391.10[M+Na-106-268]+ 0.550 224 Methyl di-substituted parishin
23 40.59 787.2303 741.10[M-H], 473.10[M-H-268], 441.10[M-H-268-H2O-14] 765.1089 659.10[M+Na-106]+, 603.10[M+Na-162]+, 497.10[M+Na-268-14]+, 391.10[M+Na-106-268]+ 0.610 224 Methyl di-substituted parishin isomer
24 42.02 1157.3546 889.10[M-H-268], 727.10[M-H-268-162], 585.10[M-H-2TMS], 423.10[M-H-2TMS-162], 379.10[M-H-2TMS-CO2-162] 1181.1189 913.10[M+Na-TMS+H2O]+, 807.10[M+Na-268-268+Glu]+, 751.10[M+Na-268-162]+, 645.10[M+Na-268-268+Glu-162]+, 483.10[M+Na-268-268-162]+ 3.271 223 Parishin glucoside
25 42.39 995.3034 727.10[M-H-268], 441.10[M-H-268-268-H2O], 423.10[M-H-268-268-2H2O], 397.10[M-H-268-268-H2O-CO2], 379.10[M-H-268-268-2H2O-CO2] 1019.1771 913.10[M+Na-106]+, 857.10[M+Na-162]+, 807.10[M+Na-106-106]+, 751.10[M+Na-268]+, 645.10[M+Na-268-268+Glu]+, 589.10[M+Na-162-268]+, 539.10[M+Na-106-106-268]+, 483.10[M+Na-268-268]+, 377.10[M+Na-106-268-268]+ 1.797 222 Parishin
26 42.81 1025.3138 757.10[M-H-268], 727.10[M-H-268-30] 1049.3097 781.10[M+Na-268]+, 751.10[M+Na-268–30]+, 645.10[M+Na-268-268+162–30]+, 483.10[M+Na-268-268-30]+ 0.760 224 Methyl parishin
27 43.01 565.1553 529.10[M-H-2H2O], 503.10[M-H-CO2-H2O], 459.10[M-H-106], 397.10[M-H-106-H2O-CO2], 173.10[M-H-268-H2O-106] 589.1525 571.10[M+Na-H2O]+, 483.10[M+Na-106]+, 215.10[M+Na-268-106]+ 0.091 224 P-hydroxybenzyl mono-substituted parishin
28 43.89 565.1556 529.10[M-H-2H2O], 503.10[M-H-CO2-H2O], 459.10[M-H-106], 397.10[M-H-106-H2O-CO2], 173.10[M-H-268-H2O-106] 589.1523 571.10[M+Na-H2O]+, 483.10[M+Na-106]+, 215.10[M+Na-268-106]+ 0.091 224 P-hydroxybenzyl mono-substituted parishin isomer
29 44.34 833.2500 727.10[M-H-106], 441.10[M-H-268-H2O-106], 397.10[M-H-268-H2O-CO2-106] 857.2483 751.10[M+Na-106]+, 645.10[M+Na-268+162–106]+, 589.10[M+Na-268]+, 483.10[M+Na-268-106]+, 377.10[M+Na-268-106-106]+ 0.893 228 P-hydroxybenzyl di-substituted parishin
30 45.91 833.2501 727.10[M-H-106], 441.10[M-H-268-H2O-106], 423.10[M-H-268-2H2O-106], 397.10[M-H-268-H2O-CO2-106], 369.10[M-3H-268-2CO2-106], 263.10[M-3H-268-2CO2-106-106] 857.2461 751.10[M+Na-106]+, 645.10[M+Na-268+162–106]+, 589.10[M+Na-268]+, 483.10[M+Na-268-106]+, 377.10[M+Na-268-106-106]+ 0.893 228 P-hydroxybenzyl di-substituted parishin isomer
31 46.18 1101.3436 995.10[M-H-106], 833.10[M-H-268], 727.10[M-H-268-106] 1125.3408 1019.10[M+Na-106]+, 857.10[M+Na -268]+, 589.10[M+Na-268-268]+, 483[M+Na-268-268-106]+ 0.984 225 P-hydroxybenzyl parishin

Mass spectra of metabolites from G. elata in both positive and negative mode showed that the characteristic ions originated mainly from functional groups such as hydroxyl and carboxyl groups. By comparing UPLC retention times and UV and mss spectral data with those of reference standards, the target peaks were tentatively identified as described below.

MSn analysis of nucleosides in G. elata

In a previous reference, two nucleosides (peaks 2 and 5) that showed similar MS fragmentation patterns, including loss of a ribose moiety (132 Da), were identified in G. elata extracts. In positive ionization mode, nucleosides mainly showed molecular ions [M+Na]+; in negative ionization mode, abundant [M-H]- or [M+HCOO]- ions were observed. By comparison with literature data [18], peak 2 was tentatively identified as uridine. In positive mode, the MS/MS spectrum focused on the precursor ion [M+Na]+ (m/z 267.0196) showed a peak corresponding to loss of a ribose moiety (m/z 113, [M+H-132]+) (Table 5). Peak 5 was tentatively identified as adenosine, based on an earlier report [20]. Its fragmentation pattern was similar to that of uridine, with a characteristic fragment at m/z 136 [M+H-132]+.

Analysis of amino acids in G. elata

Although the UV absorption of the majority of amino acids is weak, the characteristic mass spectra of four amino acids were found in G. elata extracts.

Peak 3 produced an [M+H]+ ion at m/z 182.1056 and an [M-H]- ion at m/z 180.1078, with fragment ions at m/z 165 [M+H-NH3] + and 136 [M+HCOOH]+. It can be identified as tyrosine based on a previous report [21]. Peak 4 showed an [M+H] + at m/z 132.1020 in positive ion mode and was identified as leucine. Product ions at m/z 115 [M+H-NH3]+ and 86 [M+H-HCOOH]+ were observed in the MS/MS spectrum. The MS data of peak 12 ([M+H]+ m/z 414.1331 and MS/MS m/z 285/179/233/) indicated that this compound contained m/z 285 [M+H-147+H2O]+, 179 [M+H-147+H2O-106]+ and 233 [M+H-106-75]+ groups. By comparison with an earlier report [22], peak 12 was identified as S-(4-hydroxybenzyl)-glutathione. Peak 14 showed the same behavior in the mass spectrum as peak 12 but with an additional 106 Da fragment, indicating a hydroxybenzyl linkage. MS-MS analysis of precursor ions at m/z 414 [M+H-106]+, m/z 339 [M+H-75-106]+, m/z 308 [M+H-106-106]+, m/z 285 [M+H-147+H2O-106]+, m/z 233 [M+H-106-75-]+, and m/z 179 [M+H-147+H2O-106-106]+ are characteristic of an amino linkage, and the compound was tentatively identified as p-hydroxybenzyl-S-(4-hydroxybenzyl)-glutathione.

MSn analysis of phenolic in G. elata

The external standards, parishin, parishin B, and parishin E, were used to study one to third-order collision-induced dissociation (CID) spectra (MS3) for phenolic identification. Full confidence fragmentation pathways could be achieved progressively, following comparison of product ion mass spectra of the compounds under investigation with those recorded for parishin (Fig 2). Analyses of product ion spectra of molecules [M+Na]+ provided information about the size of substituents as well as substitution patterns of parishin analogues. Similarly, for di- and mono-glycosides of parishin derivatives (9, 13, 22, 26, 29, and 31), MS/MS spectra of the [M+Na]+ ions contained either [M+Na-162]+, [M+Na-106]+, [M+Na-268]+, [M+Na-162-268]+, or [M+Na-106-268]+ (As shown in S1 Fig) The six parishin derivatives were tentatively identified as described below.

Fig 2.

Fig 2

MSn spectrum behavior of parishin (A), parishin B (B), parishin E (C) in G. elata.

Peak 9 showed an [M+Na]+ ion at m/z 645.1136, and MS/MS showed consecutive losses of 106 Da at m/z 539 [M+Na-106]+, 162 Da at m/z 483 [M+Na-162]+, 268 Da at m/z 377 [M+Na-268]+, and 430 Da at m/z 215 [M+Na-268-162]+ from the protonated molecule. The mass spectral behavior and molecular weight were confirmed in negative ion mode, with the deprotonated molecule [M-H]- at m/z 621.1660 and MS/MS showing neutral losses of glucoside, H2O and CO2, at m/z 441 [M-H-162-H2O]-, 459 [M-H-162]-, 397 [M-H-162-H2O-CO2]-, and 369 [M-H-162-CO2]-. The characteristic neutral loss of a 162 Da fragment is typically observed for parishin glucosides and glucoside is also the only substituent previously reported in G. elata [18]. Peak 9 was thus tentatively identified as mono-substituted parishin glucoside.

Peak 13 was tentatively identified as methoxy mono-substituted parishin, based on similar mass spectral behavior to peak 17 (parishin B). Peak 13 had a MW of 490, with a deprotonated molecular ion [M-H]- at m/z 489.1247 in negative ion mode. In positive ion mode, a molecular ion was observed at m/z 513.1048 [M+Na]+ and fragments were observed at m/z 414 [M+H-106]+ and 215 [M+Na-268-30]+ during the MS/MS process.

Peak 26 was tentatively identified as methyl parishin, MW 1026, with a deprotonated molecular ion [M-H]- at m/z 1025.3138 in negative mode. In positive mode, an ion was observed at m/z 1049.3097 [M+Na]+, and MS2 showed neutral losses of 268 Da and 30 Da as well as characteristic ions at m/z 781 [M+Na-268]+, m/z 751 [M+Na-268-30]+, m/z 645 [M+Na-268-268-162-30]+, and 483 [M+Na -268-268-30]+, indicating that peak 26 is a methyl-substituted parishin.

The molecular weight of peak 29 was 834, as determined by the ions observed at m/z 833.2500 [M-H]- and m/z 857.2483 [M+Na]+. MS/MS showed neutral loss of 106 (m/z 727 [M-H-106]- and m/z 751 [M+Na-106]+), as well as m/z 589 [M+Na-268]+, m/z 483 [M+Na-268-106]+, and m/z 377 [M+Na-268-106-106]+ in positive mode. In negative mode, m/z 441 [M-H-268-H2O-106]- and 397 [M-H-268-106-H2O-CO2]- were obtained. These typical fragmentations were observed for peak 29, which was tentatively identified as p-hydroxybenzyl di-substituted parishin.

Peak 31 was tentatively identified as p-hydroxybenzyl parishin, MW 1102, with a deprotonated molecular ion [M-H]—at m/z 1101.3436 in negative mode and [M+Na] + at m/z 1125.3408 in positive mode. Characteristic neutral losses of 106 Da and 268 Da were observed in the MS/MS process. The identification was confirmed by fragments obtained from the ion at m/z 995 [M-H-106]-, 833 [M-H-268]-, and 727 [M-H-268-106]-_in negative mode, as well as ions at m/z 1019 [M+Na-106]+, 857 [M+Na-268]+, 751 [M+Na-268-268]+, and 483 [M+Na-268-268-106]+ in positive mode (Table 5).

Based on literature reports [10,18,20,2326], retention times on the C18 column, UV-Vis spectra and co-elution with standards, the other peaks were identified as shown in Table 5.

Overall, thirty-one phenolic compounds were identified in fresh G. elata plant extracts in this study (Table 5). Using UPLC coupled with ESI-triple quadrupole ion MS and ESI-linear ion trap high-resolution MS, mono-substituted parishin glucoside (peak 9), methoxy mono-substituted parishin (peak 13), methyl parishin (peak 26), p-hydroxybenzyl di-substituted parishin (peak 29), p-hydroxybenzyl parishin (peak 31) were detected and identified for the first time in G. elata.

Quantitative and qualitative analysis of compounds

Significant qualitative differences were found in the metabolites detected in different species as well as in plants collected from different producing areas. Interestingly, the characteristic compound, gastrodin, was not detected in the red G. elata cultivar collected from Shanxi province. S-(4-hydroxybenzyl)-glutathione was detected only in the hybrid obtained from Sichuan province.

Compounds gastrodin, parishin E, parishin B, parishin were quantified using their available counterparts as standards, and the other parishin derivative compounds using parishin as the standard, while other compounds using gastrin as the standard. all the studied 31 compounds were classified as five groups include amino acids, nucleosides, S-(4-hydroxybenzyl)-glutathione, gastrodin, parishin derivates for further statistical analysis.

Principal component analyses

Principal component analysis (PCA) was used to provide an overview of the complete data set, showing variability between compounds detected and G. elata growth area or species. PCA using these attributes could explain 79.49% of the variance, partitioned as 43.64% in principal component 1 (PC 1) and 35.85% in principal component 2 (PC 2) (Fig 3). The loading of PC 1 showed strong positive correlations with S-(4-hydroxybenzyl)-glutathione, gastrodin, and parishin derivatives whereas PC 2 showed an important positive correlation with amino acids and nucleosides. Relationships between G. elata collection areas and detected compounds are shown in Fig 3A and Fig 3B and relationships between G. elata species and detected compounds are shown in Fig 3A and 3C.

Fig 3. Positions of PCA scores (PC1, PC2) of eight G. elata cultivars, based on amino acids, nucleosides, S-(4-hydroxybenzyl)-glutathione, gastrodin, parishin derivatives compound content.

Fig 3

The four compounds (gastrodin, parishin E, parishin B, parishin) were quantified by comparison with external standards, while the other parishin derivatives were quantified by comparison with an equivalent of parishin, and the other compounds were compared with an equivalent of gastrodin. Percentages in parentheses represent principal component variance. Numbers in figure B and C correspond to cultivar number in Table 1. (A) Sore scatter plot; (B) loading plot based on different area;(C)loading plot based on different cultivars. All the quantitative data was acquired by UPLC-ESI-triple quadrupole ion MS.

As shown in Fig 3B, the eight G. elata cultivars could be divided into four groups. Group I, comprising two G. elata cultivars (4 and 6) collected from Sichuan province, was located to the right of the PC1 axis and above the PC2 axis. G. elata cultivars collected from Sichuan province were characterized by high levels of amino acids and nucleosides. Group II consisted of one cultivar (5) from Sichuan province and was characterized by high levels of S-(4-hydroxybenzyl)-glutathione and gastrodin. Group III was located in the second quadrant and contained cultivars 2 (Guizhou, G. elata) and 7 (Shanxi, G. elata,) which have relatively high levels of amino acids. Group IV, located in the lower left part of the scatter plot, included two G. elata samples obtained from Guizhou (1 and 3) and one G. elata sample obtained from Yunnan (8) and was characterized by very low individual compound content.

PCA demonstrated a lack of strong characteristic clustering among different G. elata species. To some extent, our results show that geographic insulation affects metabolite synthesis to a greater extent than species diversity.

Conclusions

A reliable and effective method using UPLC coupled with ESI-triple quadrupole ion MS and ESI-linear ion trap high-resolution MS was successfully developed for online identification of low molecular weight metabolites of G. elata. A total of 31 compounds were identified or tentatively characterized, based mainly on fragment ion information obtained by UPLC-MS/MS. Five of these compounds were identified for the first time. PCA showed that the synthesis of G. elata metabolites varies with both species and geographic insulation. The analysis study of the active compounds in G. elata where quality control is of interest, in which case identification based on metabolites detection is possible and necessary.

Supporting Information

S1 Fig. MS/MS spectra of peak 9, peak 13, peak 26, peak 31.

(JPG)

Acknowledgments

We are grateful for financial support from the Major Scientific and Technological Special Project for ‘‘Significant New Drugs Creation” (No. 2014ZX09304307), the Major Projects of Guizhou Province ([2011] 6005) and the Major Projects of Guiyang city (2011401 No. 6–1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The authors are grateful for financial support from the National Science &Technology Pillar Program (No. 2011BAI13B04), the National Basic Research Program of China (973 Program, No. 2010CB530600), the Major Projects of Guizhou Province ([2011] 6005) and the Major Projects of Guiyang city (2011401 No. 6-1). The authors are grateful for financial support from the Major Scientific and Technological Special Project for "Significant New Drugs Creation" (No. 2014ZX09304307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Ahn EK, Jeon HJ, Lim EJ, Jung HJ, Park EH (2007) Anti-inflammatory and anti-angiogenic activities of Gastrodia elata Blume. Journal of ethnopharmacology 110: 476–482. [DOI] [PubMed] [Google Scholar]
  • 2.Kim HJ, Lee SR, Moon KD (2003) Ether fraction of methanol extracts of Gastrodia elata, medicinal herb protects against neuronal cell damage after transient global ischemia in gerbils. Phytotherapy Research 17: 909–912. [DOI] [PubMed] [Google Scholar]
  • 3.Tang W, Eisenbrand G (1992) Gastrodia elta Bl In: Chinese drugs of plant orgin. Springer-verlag Berlin; Heidelberg: 545–548. [Google Scholar]
  • 4.Zhang ZC, Su G, Li J, Wu H, Xie XD (2013) Two new neuroprotective phenolic compounds from Gastrodia elata. Journal of Asian Natural Products Research 15: 619–623. 10.1080/10286020.2013.791286 [DOI] [PubMed] [Google Scholar]
  • 5.Kim HJ, Moon KD, Oh SY, Kim SP, Lee SR (2001) Ether fraction of methanol extracts of Gastrodia elata, a traditional medicinal herb, protects against kainic acid-induced neuronal damage in the mouse hippocampus. Neuroscience Letters 314: 65–68. [DOI] [PubMed] [Google Scholar]
  • 6.Yeh CL, Leou CS, Hsu TC, Yeh CR (2011) Gastrodia sui sp. nov. (Orchidaceae) from Taiwan. Nordic Journal of Botany 29: 417–419. [Google Scholar]
  • 7.Hsieh CL, Jyh-Jian LC, Chiang SY, Su SY, Tang NY, Lin GG, et al. (2007) Gastrodia elata modulated activator protein 1 via c-Jun N-terminal kinase signaling pathway in kainic acid-induced epilepsy in rats. Journal of Ethnopharmacology 109: 241–247. [DOI] [PubMed] [Google Scholar]
  • 8.Park EJ, Lee WY, Ahn JK (2012) In vitro propagation of myco-heterotrophic Gastrodia elata. Horticulture Environment and Biotechnology 53: 415–420. [Google Scholar]
  • 9.Hsieh CL, Chiang SY, Cheng KS, Lin YH, Tang NY, Lee CJ, et al. (2001) Anticonvulsive and free radical scavenging activities of Gastrodia elata Bl. in kainic acid-treated rats. American Journal of Chinese Medicine 29: 331–341. [DOI] [PubMed] [Google Scholar]
  • 10.Ha JH, Lee DU, Lee JT, Kim JS, Yong CS, Kim JA, et al. (2000) 4-hydroxybenzaldehyde from Gastrodia elata B1. is active in the antioxidation and GABAergic neuromodulation of the rat brain. Journal of Ethnopharmacology 73: 329–333. [DOI] [PubMed] [Google Scholar]
  • 11.Wu CR, Hsieh MT, Huang SC, Peng WH, Chang YS, Chen CF (1996) Effects of Gastrodia elata and its active constituents on scopolamine-induced amnesia in rats. Planta Medica 317–321. [DOI] [PubMed] [Google Scholar]
  • 12.Wang HX, Yang T, Zeng Y, Hu Z (2007) Expression analysis of the gastrodianin gene ga4B in an achlorophyllous plant Gastrodia elata Bl. Plant Cell Reports 26: 253–259. [DOI] [PubMed] [Google Scholar]
  • 13.Cox KD, Layne DR, Scorza R, Schnabel G (2006) Gastrodia anti-fungal protein from the orchid Gastrodia elata confers disease resistance to root pathogens in transgenic tobacco. Planta 224: 1373–1383. [DOI] [PubMed] [Google Scholar]
  • 14.Yu SJ, Kim JR, Lee CK, Han JE, Lee JH, Kim HS, et al. (2005) Gastrodia elata blume and an active component, p-hydroxybenzyl alcohol reduce focal ischemic brain injury through antioxidant related gene expressions. Biological & Pharmaceutical Bulletin 28: 1016–1020. [DOI] [PubMed] [Google Scholar]
  • 15.Pharmacopoeia Committee of PR China E (2000) Chinese Pharmacopoeia: Chemical Industry Publishing House, Beijing. [Google Scholar]
  • 16.Li Z, Wang Y, Ouyang H, Lu Y, Qiu Y, Feng Y, et al. (2015) A novel dereplication strategy for the identification of two new trace compounds in the extract of Gastrodia elata using UHPLC/Q-TOF-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 988: 45–52. 10.1016/j.jchromb.2015.02.020 [DOI] [PubMed] [Google Scholar]
  • 17.Chen S, Fang LC, Xi HF, Guan L, Fang JB, Liu YL, et al. (2012) Simultaneous qualitative assessment and quantitative analysis of flavonoids in various tissues of lotus (Nelumbo nucifera) using high performance liquid chromatography coupled with triple quad mass spectrometry. Analytica Chimica Acta 724: 127–135. 10.1016/j.aca.2012.02.051 [DOI] [PubMed] [Google Scholar]
  • 18.Wang L, Xiao HB, Liang XM, Wei LX (2007) Identification of phenolics and nucleoside derivatives in Gastrodia elata by HPLC-UV-MS. Journal of Separation Science 30: 1488–1495. [DOI] [PubMed] [Google Scholar]
  • 19.Ong ES, Heng MY, Tan SN, Yong JWH, Koh H, Teo CC, et al. (2007) Determination of gastrodin and vanillyl alcohol in Gastrodia elata Blume by pressurized liquid extraction at room temperature. Journal of Separation Science 30: 2130–2137. [DOI] [PubMed] [Google Scholar]
  • 20.Hayashi J, Sekine T, Deguchi S, Lin Q, Horie S, Tsuchiya S, et al. (2002) Phenolic compounds from Gastrodia rhizome and relaxant effects of related compounds on isolated smooth muscle preparation. Phytochemistry 59: 513–519. [DOI] [PubMed] [Google Scholar]
  • 21.Wang L, Xiao HB, Liang XM (2009) Chemical constituents from Gastrodia elata. Chinese Traditional and Herbal Drugs 40: 1186–1189. [Google Scholar]
  • 22.Wang L, Xiao HB (2009) Progress in the study of quality control and active components of Gastrodia elata. Chinese Traditional and Herbal Drugs 40. [Google Scholar]
  • 23.Ahn EK, Jeon HJ, Lim EJ, Jung HJ, Park EH (2007) Anti-inflammatory and anti-angiogenic activities of Gastrodia elata Blume. Journal of Ethnopharmacology 110: 476–482. [DOI] [PubMed] [Google Scholar]
  • 24.Choi JH, Lee DU (2006) A new citryl glycoside from Gastrodia elata and its inhibitory activity on GABA transaminase. Chemical & Pharmaceutical Bulletin 54: 1720–1721. [DOI] [PubMed] [Google Scholar]
  • 25.Li HB, Chen F (2004) Preparative isolation and purification of gastrodin from the Chinese medicinal plant Gastrodia elata by high-speed counter-current chromatography. Journal of Chromatography A 1052: 229–232. [DOI] [PubMed] [Google Scholar]
  • 26.Wang L, Xiao HB, Yang L, Wang ZT (2012) Two new phenolic glycosides from the rhizome of Gastrodia elata. Journal of Asian Natural Products Research 14: 457–462. 10.1080/10286020.2012.669755 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 Fig. MS/MS spectra of peak 9, peak 13, peak 26, peak 31.

(JPG)

Data Availability Statement

All relevant data are within the paper and its Supporting Information files.


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES